A randomized, double-blind, placebo-controlled, phase III study of the safety and efficacy of interferon-γ-1b in patients with idiopathic pulmonary fibrosis (The INSPIRE Trial: International Study of Survival Outcomes in IPF with Interferon gamma-1b)